We are Sorry, This Page doesn't Exist
AstraZeneca triple-combination COPD therapy approved in China
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
AstraZeneca"s Triple Combo Lung Cancer Therapy Aces Late-Stage Trial
AstraZeneca plc (NYSE: AZN) shares were advancing Monday following a clinical readout from the company. What Happened The U.K.-based pharma giant said its Phase 3 POSEIDON trial produced positive results. read more.....»»
Vertex Hits Stumbling Block For One Triple-Combo Therapy For Cystic Fibrosis
Vertex Hits Stumbling Block For One Triple-Combo Therapy For Cystic Fibrosis.....»»
TG Therapeutics announces publication of data from triple therapy combo trial
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Lilly says late-stage study showed combo therapy can reduce deaths and hospitalizations in COVID-19 patients
Shares of Eli Lilly & Co. were up 0.3% in premarket trading on Tuesday after the drugmaker said combining two of its experimental COVID-19 antibod.....»»
The Week Ahead In Biotech (March 8-14): Bristol-Myers Awaits FDA Nod For Liver Cancer Combo Therapy, Earnings Flow Continues
Biotech stocks rebounded in the week ended March 6, recovering from the previous week's steep sell-off. The week was light on news flow, barring some smid-cap earnings and COVID-19 treatment and.....»»
The Week Ahead In Biotech (March 8-14): Bristol-Myers Awaits FDA Nod For Liver Cancer Combo Therapy, Earnings Flow Continues
Biotech stocks rebounded in the week ended March 6, recovering from the previous week's steep sell-off. The week was light on news flow, barring some smid-cap earnings and COVID-19 treatment and vaccine news. read more.....»»
Spring Bank to add CASOs to NUCs for triple therapy, says Piper Jaffray
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
TG Therapeutics reports triple therapy data from Phase I/II study of ublitux
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Eisai"s Cancer Drug Combo Gets Breakthrough Therapy Designation For Liver Cancer
Japanese drug maker Eisai Co., Ltd (OTC: ESALY) has some positive news concerning one of its pipeline candidates. read more.....»»
Merck"s Keytruda Gets EU Approval for Difficult Lung Cancer
Merck (MRK) receives approval for Keytruda's combo therapy for first-line treatment of metastatic squamous non-small cell lung cancer po.....»»
Innoviva IMPACT Trelegy Ellipta COPD study published in NEJM
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Glaxo to Sell Rare Disease Gene Therapies to Private Biotech
Glaxo (GSK) will divest its rare disease gene therapy drugs to private biotech Orch.....»»
Your Daily Pharma Scoop: Abeona Presents Strong Data, Glaxo Nucala Treatment Benefit, Rocket Pharma"s Gene Therapy Data
Your Daily Pharma Scoop: Abeona Presents Strong Data, Glaxo Nucala Treatment Benefit, Rocket Pharma"s Gene Therapy Data.....»»
ResMed Releases Positive U.S. & U.K. Study Data on COPD
ResMed (RMD) presents the company-sponsored health economic studies, Home Oxygen Therapy-Home Mechanical Ventilation (HOT-HMV), at the ATS 2018 International Conference. ResMed Inc. RMD recently demonstrated a favorable outcome from two .....»»
GSK submits application in Japan for once-daily single inhaler triple therapy
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Glaxo/Innoviva File for Approval of Trelegy Ellipta in Japan
Glaxo and Innoviva f.....»»
Merck, Eisai announce data from LENVIMA/KEYTRUDA combo therapy
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Glaxo Two-Drug HIV Combo Meets Primary Endpoint in Phase III
Glaxo's (GSK) two late-stage studies testing its two-drug HIV regimen of dolutegravir (Tivicay) and lamivudine showed non-infer.....»»
Infinity and Arcus Ink Deal for Two Triple Combo Studies
: Infini.....»»